Nanosecond laser therapy reverses pathologic and molecular changes in age-related macular degeneration without retinal damage

FASEB Journal

Volumn 29, Issue 2, 2015, Pages 696-710

  Jobling, A I ^a   Guymer, R H ^a   Vessey, K A ^a   Greferath, U ^a   Mills, S A ^a   Brassington, K H ^a   Luu, C D ^a   Aung, K Z ^a   Trogrlic, L ^a   Plunkett, M ^b   Fletcher, E L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Ellex Medical Lasers R and D   (Australia)

Author keywords

Bruch's membrane; Drusen; Matrix metalloproteinase; Vision loss

Indexed keywords

GELATINASE A; STROMELYSIN; MATRIX METALLOPROTEINASE;

AGE RELATED MACULAR DEGENERATION; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCH MEMBRANE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUSEN; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW LEVEL LASER THERAPY; MONONUCLEAR CELL; MOUSE; NANOSECOND LASER THERAPY; NONHUMAN; POLYMERASE CHAIN REACTION; PRESERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETINA INJURY; AGING; ANIMAL; C57BL MOUSE; CLINICAL TRIAL; MACULAR DEGENERATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; PILOT STUDY; PROSPECTIVE STUDY; RETINA; RETINAL DISEASES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ANIMALS; BRUCH MEMBRANE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LASER THERAPY; MACULAR DEGENERATION; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MIDDLE AGED; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RETINA; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM;

EID: 84937410702     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-262444     Document Type: Article

References (86)

1. United Nations, Department of Economic and Social Affairs, Population Division. (2013) World Population Prospects: The 2012 Revision, Highlights and Advance Tables. Working Paper No. ESA/P/WP.228. Retrieved November 6, 2014, from http:// esa.un.org/wpp/Documentation/pdf/WPP2012-HIGHLIGHTS.pdf
2. Congdon, N., O'Colmain, B., Klaver, C. C., Klein, R., Muñoz, B., Friedman, D. S., Kempen, J., Taylor, H. R., and Mitchell, P.; Eye Diseases Prevalence Research Group. (2004) Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 122, 477-485
3. Mitchell, P., Smith, W., Attebo, K., and Wang, J. J. (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102, 1450-1460
4. Khandhadia, S., Cherry, J., and Lotery, A. J. (2012) Age-related macular degeneration. Adv. Exp. Med. Biol. 724, 15-36
5. Ambati, J., and Fowler, B. J. (2012) Mechanisms of age-related macular degeneration. Neuron 75, 26-39
6. Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., and Schneider, S.; ANCHOR Study Group. (2006) Ranibizumab versus verteporfin for neovascular agerelated macular degeneration. N. Engl. J. Med. 355, 1432-1444
7. Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., and Kim, R. Y.; MARINA Study Group. (2006) Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419-1431
8. Gillies, M. C., Walton, R., Simpson, J. M., Arnold, J. J., Guymer, R. H., McAllister, I. L., Hunyor, A. P., Essex, R. W., Morlet, N., and Barthelmes, D.; Fight Retinal Blindness! Project Investigators. (2013) Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes. Invest. Ophthalmol. Vis. Sci. 54, 5754-5760
9. Boekhoorn, S. S., Vingerling, J. R., Witteman, J. C., Hofman, A., and de Jong, P. T. (2007) C-reactive protein level and risk of aging macula disorder: The Rotterdam Study. Arch. Ophthalmol. 125, 1396-1401
10. Guymer, R. H., Tao, L. W., Goh, J. K., Liew, D., Ischenko, O., Robman, L. D., Aung, K., Cipriani, T., Cain, M., Richardson, A. J., Baird, P. N., and Langham, R. (2011) Identification of urinary biomarkers for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 52, 4639-4644
11. Ferris III, F. L., Wilkinson, C. P., Bird, A., Chakravarthy, U., Chew, E., Csaky, K., and Sadda, S. R.; Beckman Initiative for Macular Research Classification Committee. (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120, 844-851
12. Hageman, G. S., Luthert, P. J., Victor Chong, N. H., Johnson, L. V., Anderson, D. H., and Mullins, R. F. (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20, 705-732
13. Gass, J. D. (1972) Drusen and disciform macular detachment and degeneration. Trans. Am. Ophthalmol. Soc. 70, 409-436
14. Gass, J. D. (1973) Drusen and disciform macular detachment and degeneration. Arch. Ophthalmol. 90, 206-217
15. Sarks, S. H. (1980) Council Lecture. Drusen and their relationship to senile macular degeneration. Aust. J. Ophthalmol. 8, 117-130
16. Sarks, S. H. (1982) Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust. J. Ophthalmol. 10, 91-97
17. Rudolf, M., Clark, M. E., Chimento, M. F., Li, C. M., Medeiros, N. E., and Curcio, C. A. (2008) Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 49, 1200-1209
18. Bressler, S. B., Maguire, M. G., Bressler, N. M., and Fine, S. L.; The Macular Photocoagulation Study Group. (1990) Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch. Ophthalmol. 108, 1442-1447
19. Karampelas, M., Sim, D. A., Keane, P. A., Papastefanou, V. P., Sadda, S. R., Tufail, A., and Dowler, J. (2013) Evaluation of retinal pigment epithelium-Bruch's membrane complex thickness in dry age-related macular degeneration using optical coherence tomography. Br. J. Ophthalmol. 97, 1256-1261
20. Starita, C., Hussain, A. A., Pagliarini, S., and Marshall, J. (1996) Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp. Eye Res. 62, 565-572
21. Pauleikhoff, D., Chen, J. C., Chisholm, I. H., and Bird, A. C. (1990) Choroidal perfusion abnormality with age-related Bruch's membrane change. Am. J. Ophthalmol. 109, 211-217
22. Hussain, A. A., Starita, C., Hodgetts, A., and Marshall, J. (2010) Macromolecular diffusion characteristics of ageing human Bruch's membrane: implications for age-related macular degeneration (AMD). Exp. Eye Res. 90, 703-710
23. Ahir, A., Guo, L., Hussain, A. A., and Marshall, J. (2002) Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 43, 458-465
24. Barathi, V. A., Yeo, S. W., Guymer, R. H., Wong, T. Y., and Luu, C. D. (2014) Effects of simvastatin on retinal structure and function of a high-fat atherogenic mouse model of thickened Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 55, 460-468
25. Olk, R. J., Friberg, T. R., Stickney, K. L., Akduman, L., Wong, K. L., Chen, M. C., Levy, M. H., Garcia, C. A., and Morse, L. S. (1999) Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology 106, 2082-2090
26. Guymer, R. H., Gross-Jendroska, M., Owens, S. L., Bird, A. C., and Fitzke, F. W. (1997) Laser treatment in subjects with highrisk clinical features of age-related macular degeneration. Posterior pole appearance and retinal function. Arch. Ophthalmol. 115, 595-603
27. Parodi, M. B., Virgili, G., and Evans, J. R. (2009) Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst. Rev. (3):CD006537
28. Guymer, R. H., Hageman, G. S., and Bird, A. C. (2001) Influence of laser photocoagulation on choroidal capillary cytoarchitecture. Br. J. Ophthalmol. 85, 40-46
29. Duvall, J., and Tso, M. O. (1985) Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study. Arch. Ophthalmol. 103, 694-703
30. Yamamoto, C., Ogata, N., Yi, X., Takahashi, K., Miyashiro, M., Yamada, H., Uyama, M., and Matsuzaki, K. (1996) Immunolocalization of basic fibroblast growth factor during wound repair in rat retina after laser photocoagulation. Graefes Arch. Clin. Exp. Ophthalmol. 234, 695-702
31. Zhang, J. J., Sun, Y., Hussain, A. A., and Marshall, J. (2012) Laser-mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases. Invest. Ophthalmol. Vis. Sci. 53, 2928-2937
32. Frennesson, C., and Nilsson, S. E. (1998) Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications. Br. J. Ophthalmol. 82, 1169-1174
33. Little, H. L., Showman, J. M., and Brown, B. W. (1997) A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen. Ophthalmology 104, 623-631
34. Friberg, T. R., Musch, D. C., Lim, J. I., Morse, L., Freeman, W., and Sinclair, S. (2006) Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients. Ophthalmology 113, 622.e1
35. Choroidal Neovascularization Prevention Trial Research Group. (2003) Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology 110, 971-978
36. Mojana, F., Brar, M., Cheng, L., Bartsch, D. U., and Freeman, W. R. (2011) Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after subthreshold infrared laser treatment of drusen. Retina 31, 235-242
37. Wood, J. P., Plunkett, M., Previn, V., Chidlow, G., and Casson, R. J. (2011) Nanosecond pulse lasers for retinal applications. Lasers Surg. Med. 43, 499-510
38. Wood, J. P., Shibeeb, O., Plunkett, M., Casson, R. J., and Chidlow, G. (2013) Retinal damage profiles and neuronal effects of laser treatment: comparison of a conventional photocoagulator and a novel 3-nanosecond pulse laser. Invest. Ophthalmol. Vis. Sci. 54, 2305-2318
39. Chidlow, G., Shibeeb, O., Plunkett, M., Casson, R. J., and Wood, J. P. (2013) Glial cell and inflammatory responses to retinal laser treatment: comparison of a conventional photocoagulator and a novel, 3-nanosecond pulse laser. Invest. Ophthalmol. Vis. Sci. 54, 2319-2332
40. Pelosini, L., Hamilton, R., Mohamed, M., Hamilton, A. M., and Marshall, J. (2013) Retina rejuvenation therapy for diabetic macular edema: a pilot study. Retina 33, 548-558
41. Guymer, R. H., Brassington, K. H., Dimitrov, P., Makeyeva, G., Plunkett, M., Xia, W., Chauhan, D., Vingrys, A., and Luu, C. D. (2014) Nanosecond-laser application in intermediate AMD: 12-month results of fundus appearance and macular function. Clin. Experiment. Ophthalmol. 42, 466-479
42. Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., and Littman, D. R. (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106-4114
43. Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., and Maeda, N. (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA 89, 4471-4475
44. Complications of Age-Related Macular Degeneration Prevention Trial Research Group. (2006) Laser treatment in patients with bilateral large drusen: the complications of agerelated macular degeneration prevention trial. Ophthalmology 113, 1974-1986
45. Delori, F. C., Dorey, C. K., Staurenghi, G., Arend, O., Goger, D. G., and Weiter, J. J. (1995) In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest. Ophthalmol. Vis. Sci. 36, 718-729
46. Schmitz-Valckenberg, S., Fleckenstein, M., Scholl, H. P., and Holz, F. G. (2009) Fundus autofluorescence and progression of age-related macular degeneration. Surv. Ophthalmol. 54, 96-117
47. Toy, B. C., Krishnadev, N., Indaram, M., Cunningham, D., Cukras, C. A., Chew, E. Y., and Wong, W. T. (2013) Drusen regression is associated with local changes in fundus autofluorescence in intermediate age-related macular degeneration. Am. J. Ophthalmol. 156, 532, e1
48. Thévenaz, P., Ruttimann, U. E., and Unser, M. (1998) A pyramid approach to subpixel registration based on intensity. IEEE Trans. Image Process. 7, 27-41
49. Vessey, K. A., Greferath, U., Jobling, A. I., Phipps, J. A., Ho, T., Waugh, M., and Fletcher, E. L. (2012) Ccl2/Cx3cr1 knockout mice have inner retinal dysfunction but are not an accelerated model of AMD. Invest. Ophthalmol. Vis. Sci. 53, 7833-7846
50. Jobling, A. I., Vessey, K. A., Waugh, M., Mills, S. A., and Fletcher, E. L. (2013) A naturally occurring mouse model of achromatopsia: characterization of the mutation in cone transducin and subsequent retinal phenotype. Invest. Ophthalmol. Vis. Sci. 54,3350-3359
51. Eliasieh, K., Liets, L. C., and Chalupa, L. M. (2007) Cellular reorganization in the human retina during normal aging. Invest. Ophthalmol. Vis. Sci. 48, 2824-2830
52. Vessey, K. A., Wilkinson-Berka, J. L., and Fletcher, E. L. (2011) Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy. J. Comp. Neurol. 519, 506-527
53. Rhodes, K. M., Weinstein, R., Saltzmann, R. M., Aggarwal, N., Kooner, K. S., Petroll, W. M., and Whitson, J. T. (2009) Intraocular pressure reduction in the untreated fellow eye after selective laser trabeculoplasty. Curr. Med. Res. Opin. 25, 787-796
54. Klein, M. L., Ferris III, F. L., Armstrong, J., Hwang, T. S., Chew, E. Y., Bressler, S. B., and Chandra, S. R.; AREDS Research Group. (2008) Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology 115, 1026-1031
55. Holz, F. G., Bindewald-Wittich, A., Fleckenstein, M., Dreyhaupt, J., Scholl, H. P., and Schmitz-Valckenberg, S.; FAM-Study Group. (2007) Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am. J. Ophthalmol. 143, 463-472
56. Fletcher, E. L., Jobling, A. I., Vessey, K. A., Luu, C., Guymer, R. H., and Baird, P. N. (2011) Animal models of retinal disease. Prog. Mol. Biol. Transl. Sci. 100, 211-286
57. Eter, N., Engel, D. R., Meyer, L., Helb, H. M., Roth, F., Maurer, J., Holz, F. G., and Kurts, C. (2008) In vivo visualization of dendritic cells, macrophages, and microglial cells responding to laserinduced damage in the fundus of the eye. Invest. Ophthalmol. Vis. Sci. 49, 3649-3658
58. Lech, M., Gröbmayr, R., Weidenbusch, M., and Anders, H. J. (2012) Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments. Mediators Inflamm. 2012, 951390
59. Ambati, J., Atkinson, J. P., and Gelfand, B. D. (2013) Immunology of age-related macular degeneration. Nat. Rev. Immunol. 13, 438-451
60. Diaz-Araya, C. M., Provis, J. M., Penfold, P. L., and Billson, F. A. (1995) Development of microglial topography in human retina. J. Comp. Neurol. 363, 53-68
61. Cashman, S. M., Desai, A., Ramo, K., and Kumar-Singh, R. (2011) Expression of complement component 3 (C3) from an adenovirus leads to pathology in the murine retina. Invest. Ophthalmol. Vis. Sci. 52, 3436-3445
62. Dithmar, S., Curcio, C. A., Le, N. A., Brown, S., and Grossniklaus, H. E. (2000) Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest. Ophthalmol. Vis. Sci. 41, 2035-2042
63. Kumar, A., El-Osta, A., Hussain, A. A., and Marshall, J. (2010) Increased sequestration of matrix metalloproteinases in ageing human Bruch's membrane: implications for ECM turnover. Invest. Ophthalmol. Vis. Sci. 51, 2664-2670
64. Kamei, M., and Hollyfield, J. G. (1999) TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 40, 2367-2375
65. Bressler, N. M., Munoz, B., Maguire, M. G., Vitale, S. E., Schein, O. D., Taylor, H. R., and West, S. K. (1995) Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch. Ophthalmol. 113, 301-308
66. Rodanant, N., Friberg, T. R., Cheng, L., Aurora, A., Bartsch, D., Toyoguchi, M., Corbin, P. S., El-Bradey, M. H., and Freeman, W. R. (2002) Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration. Am. J. Ophthalmol. 134, 577-585
67. Figueroa, M. S., Regueras, A., and Bertrand, J. (1994) Laser photocoagulation to treat macular soft drusen in age-related macular degeneration. Retina 14, 391-396
68. Gass, J. D. (1971) Photocoagulation of macular lesions. Trans. Am. Acad. Ophthalmol. Otolaryngol. 75, 580-608
69. Sigelman, J. (1991) Foveal drusen resorption one year after perifoveal laser photocoagulation. Ophthalmology 98, 1379-1383
70. Birngruber, R., Gabel, V. P., and Hillenkamp, F. (1983) Experimental studies of laser thermal retinal injury. Health Phys. 44, 519-531
71. Roider, J., Michaud, N., Flotte, T., and Birngruber, R. (1993) [Histology of retinal lesions after continuous irradiation and selective micro-coagulation of the retinal pigment epithelium]. Ophthalmologe 90, 274-278
72. Wallow, I. H., and Tso, M. O. (1973) Repair after xenon arc photocoagulation. 2. A clinical and light microscopic study of the evolution of retinal lesions in the rhesus monkey. Am. J. Ophthalmol. 75, 610-626
73. Pollack, J. S., Kim, J. E., Pulido, J. S., and Burke, J. M. (1998) Tissue effects of subclinical diode laser treatment of the retina. Arch. Ophthalmol. 116, 1633-1639
74. Lanzetta, P., Polito, A., and Veritti, D. (2008) Subthreshold laser. Ophthalmology 115, 216, e1
75. Kaur, C., Rathnasamy, G., and Ling, E. A. (2013) Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J. Neuroimmune Pharmacol. 8, 66-78
76. Chen, J., Connor, K. M., and Smith, L. E. (2007) Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration. J. Clin. Invest. 117, 2758-2762
77. Alexander, J. P., Bradley, J. M., Gabourel, J. D., and Acott, T. S. (1990) Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 31, 2520-2528
78. Guo, L., Hussain, A. A., Limb, G. A., and Marshall, J. (1999) Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest. Ophthalmol. Vis. Sci. 40, 2676-2682
79. Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G., and Bergen, A. A. (2010) The dynamic nature of Bruch's membrane. Prog. Retin. Eye Res. 29, 1-18
80. Hussain, A. A., Lee, Y., Zhang, J. J., and Marshall, J. (2011) Disturbed matrix metalloproteinase activity of Bruch's membrane in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 52, 4459-4466
81. Treumer, F., Klettner, A., Baltz, J., Hussain, A. A., Miura, Y., Brinkmann, R., Roider, J., and Hillenkamp, J. (2012) Vectorial release of matrix metalloproteinases (MMPs) from porcine RPE-choroid explants following selective retina therapy (SRT): towards slowing the macular ageing process. Exp. Eye Res. 97, 63-72
82. Pauleikhoff, D., Wojteki, S., Müller, D., Bornfeld, N., and Heiligenhaus, A. (2000) [Adhesive properties of basal membranes of Bruch's membrane. Immunohistochemical studies of age-dependent changes in adhesive molecules and lipid deposits]. Ophthalmologe 97, 243-250
83. Gullapalli, V. K., Sugino, I. K., Van Patten, Y., Shah, S., and Zarbin, M. A. (2005) Impaired RPE survival on aged submacular human Bruch's membrane. Exp. Eye Res. 80, 235-248
84. Gullapalli, V. K., Sugino, I. K., and Zarbin, M. A. (2008) Culture-induced increase in alpha integrin subunit expression in retinal pigment epithelium is important for improved resurfacing of aged human Bruch's membrane. Exp. Eye Res. 86, 189-200
85. Sugino, I. K., Gullapalli, V. K., Sun, Q., Wang, J., Nunes, C. F., Cheewatrakoolpong, N., Johnson, A. C., Degner, B. C., Hua, J., Liu, T., Chen, W., Li, H., and Zarbin, M. A. (2011) Cell-deposited matrix improves retinal pigment epithelium survival on aged submacular human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 52, 1345-1358
86. Moore, D. J., Hussain, A. A., and Marshall, J. (1995) Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 36, 1290-1297